Investeringsoversigt

186 Investeringer

Titel Sortér faldende	Periode	Program
A coherent approach to virtual assessments of structural robustness	2019 - 2022	Erhvervsforsker
A coherent approach to virtual assessments of structural robustness Periode 2019 - 2022 Region Region Hovedstaden Program Erhvervsforsker Fagområde Biotek, Medico og Sundhed Investering Percentage 54.86 Fondens investering 1,1 mio. Samlet budget 2,0 mio. Projektdeltagere Technical University of Denmark, Novo Nordisk A/S Projektleder Novo Nordisk A/S Læs mere om projektet
A molecular display platform for screening and direct selection of functionally active peptides	2019 - 2021	Erhvervsforsker
A molecular display platform for screening and direct selection of functionally active peptides Periode 2019 - 2021 Region Region Hovedstaden Program Erhvervsforsker Fagområde Biotek, Medico og Sundhed Investering Percentage 45.61 Fondens investering 828.000 Samlet budget 1,8 mio. Projektdeltagere Danmarks Tekniske Universitet, ZEALAND PHARMA A/S Projektleder ZEALAND PHARMA A/S Læs mere om projektet
A New Approach for Stability and Immunogenicity Assessment of Biopharmaceuticals	2019 - 2022	Erhvervsforsker
A New Approach for Stability and Immunogenicity Assessment of Biopharmaceuticals Periode 2019 - 2022 Region Region Hovedstaden Program Erhvervsforsker Fagområde Biotek, Medico og Sundhed Investering Percentage 47.06 Fondens investering 1,1 mio. Samlet budget 2,3 mio. Projektdeltagere University of Copenhagen, Fida Biosystems ApS Projektleder Fida Biosystems ApS Læs mere om projektet
A new cost-neutral injection pen as an alternative to syringes for the 12 million resource poor people buying insulin in vials though minimum feature innovation	2019 - 2020	Innofounder
A new cost-neutral injection pen as an alternative to syringes for the 12 million resource poor people buying insulin in vials though minimum feature innovation Periode 2019 - 2020 Region Region Hovedstaden Program Innofounder Fagområde Biotek, Medico og Sundhed Investering Percentage 100 Fondens investering 460.000 Samlet budget 460.000 Projektdeltagere GO-PEN ApS Projektleder GO-PEN ApS Læs mere om projektet
Accelerating vaccine development through a deep learning and probabilistic programming approach to protein structure prediction	2019 - 2022	Erhvervsforsker
Accelerating vaccine development through a deep learning and probabilistic programming approach to protein structure prediction Periode 2019 - 2022 Region Region Hovedstaden Program Erhvervsforsker Fagområde Biotek, Medico og Sundhed Investering Percentage 42.6 Fondens investering 1,1 mio. Samlet budget 2,5 mio. Projektdeltagere University of Copenhagen, EVAXION BIOTECH A/S Projektleder EVAXION BIOTECH A/S Læs mere om projektet
ACD-plugin – a disinfective easy-to-install solution for improvement of air quality in cars	2019 - 2020	Innobooster
ACD-plugin – a disinfective easy-to-install solution for improvement of air quality in cars Periode 2019 - 2020 Region Region Hovedstaden Program Innobooster Fagområde Biotek, Medico og Sundhed Investering Percentage 33 Fondens investering 490.050 Samlet budget 1,5 mio. Projektdeltagere AirClean Denmark ApS Projektleder ACD ApS Læs mere om projektet
ADCendo ApS - A biotech spinout developing novel anti-cancer drugs in the form of antibody drug conjugates (ADCs)	2019 - 2020	Innobooster
ADCendo ApS - A biotech spinout developing novel anti-cancer drugs in the form of antibody drug conjugates (ADCs) Periode 2019 - 2020 Region Region Hovedstaden Program Innobooster Fagområde Biotek, Medico og Sundhed Investering Percentage 30 Fondens investering 483.600 Samlet budget 1,6 mio. Projektdeltagere ADCendo ApS Projektleder ADCendo ApS Læs mere om projektet
ADCendo ApS - first-in-class targeted cancer drugs	2019 - 2020	Innofounder
ADCendo ApS - first-in-class targeted cancer drugs Periode 2019 - 2020 Region Region Hovedstaden Program Innofounder Fagområde Biotek, Medico og Sundhed Investering Percentage 100 Fondens investering 460.000 Samlet budget 460.000 Projektdeltagere ADCendo ApS Projektleder ADCendo ApS Læs mere om projektet
Adherence through cloud-based Personalised Treatment for Type 2 Diabetes ADAPT-T2D ADAPT-T2D	2019 - 2024	Grand Solutions
Adherence through cloud-based Personalised Treatment for Type 2 Diabetes ADAPT-T2D ADAPT-T2D Periode 2019 - 2024 Region Region Hovedstaden Program Grand Solutions Fagområde Biotek, Medico og Sundhed Investering Percentage 52.12 Fondens investering 17,1 mio. Samlet budget 32,9 mio. Projektdeltagere Novo Nordisk A/S, Aalborg Universitetshospital, Region Sjælland, Aalborg University, Technical University of Denmark, University of Cambridge, Glooko AB Projektleder NOVO NORDISK A/S Læs mere om projektet
Advanced characterization of large scale fermentations	2019 - 2021	Erhvervsforsker
Advanced characterization of large scale fermentations Periode 2019 - 2021 Region Region Hovedstaden Program Erhvervsforsker Fagområde Biotek, Medico og Sundhed Investering Percentage 46.94 Fondens investering 828.000 Samlet budget 1,8 mio. Projektdeltagere Technical University of Denmark, FreeSense ApS Projektleder FreeSense ApS Læs mere om projektet
Advanced modelling for prediction and control of related substances in an antibiotic fermentation processes	2019 - 2022	Erhvervsforsker
Advanced modelling for prediction and control of related substances in an antibiotic fermentation processes Periode 2019 - 2022 Region Region Hovedstaden Program Erhvervsforsker Fagområde Biotek, Medico og Sundhed Investering Percentage 47.73 Fondens investering 1,1 mio. Samlet budget 2,2 mio. Projektdeltagere Technical University of Denmark, LEO PHARMA A/S Projektleder LEO PHARMA A/S Læs mere om projektet
Advancing biological solutions for biofouling	2019 - 2022	Erhvervsforsker
Advancing biological solutions for biofouling Periode 2019 - 2022 Region Region Hovedstaden Program Erhvervsforsker Fagområde Biotek, Medico og Sundhed Investering Percentage 56.02 Fondens investering 1,1 mio. Samlet budget 1,9 mio. Projektdeltagere Aarhus University, Novozymes A/S Projektleder Novozymes A/S Læs mere om projektet
Advancing KP405 - A Novel, First-in-Class, Disease Modifying Treatment for Parkinson's Disease	2019 - 2020	Innobooster
Advancing KP405 - A Novel, First-in-Class, Disease Modifying Treatment for Parkinson's Disease Periode 2019 - 2020 Region Region Hovedstaden Program Innobooster Fagområde Biotek, Medico og Sundhed Investering Percentage 33 Fondens investering 4,0 mio. Samlet budget 12,0 mio. Projektdeltagere Kariya Pharmaecuticals IVS Projektleder Kariya Pharmaceuticals ApS Læs mere om projektet
Affective Design for improved Health Outcomes for Rheumatology Patients using Digital Health Technology	2019 - 2022	Erhvervsforsker
Affective Design for improved Health Outcomes for Rheumatology Patients using Digital Health Technology Periode 2019 - 2022 Region Region Hovedstaden Program Erhvervsforsker Fagområde Biotek, Medico og Sundhed Investering Percentage 51.29 Fondens investering 1,1 mio. Samlet budget 2,1 mio. Projektdeltagere IT University of Copenhagen, DAMAN P/S Projektleder DAMAN P/S Læs mere om projektet
Algoritme for udmåling af hjertets dyssynkroni baseret på asymmetri af kontraktion	2019 - 2020	Innoexplorer
Algoritme for udmåling af hjertets dyssynkroni baseret på asymmetri af kontraktion Periode 2019 - 2020 Region Region Nordjylland Program Innoexplorer Fagområde Biotek, Medico og Sundhed Investering Percentage 100 Fondens investering 1,1 mio. Samlet budget 1,1 mio. Projektdeltagere Aalborg Universitetshospital Syd Projektleder Aalborg Universitetshospital Syd Læs mere om projektet